PMV Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:PMVP)

Financials

Cash from operating activities -16.66 M-18.27 M-18.3 M-19.82 M-17.19 M -73.58 M Cash from investing activities 7.74 M28.71 M10.99 M12.03 M18.44 M 70.17 M Cash from financing activities 172 K10 K103 K0392 K 505 K Free cash flow -16.72 M-18.27 M-18.31 M-19.82 M-17.2 M -73.6 M

Nouvelles

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed Advisors vend des actions PMV Pharma (PMVP) pour 1,52 million $

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

Le titre de PMV Pharmaceuticals grimpe suite à des données positives d’essai de médicament contre le cancer

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma présentera des données initiales sur le traitement des mutations TP53

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

PMV Pharmaceuticals conserve sa note d’achat chez H.C. Wainwright suite aux données d’essai

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)

TD Cowen maintient sa recommandation d’achat pour l’action PMV Pharmaceuticals